Stem cells transplantation - A cure for autoimmune diseases

Lupus

Volumn 7, Issue 3, 1998, Pages 137-140

  Sherer, Y ^a   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti phospholipid syndrome; Autoimmune diseases; Stem cells transplantation; Systemic lupus erythematosus

Indexed keywords

ANIMAL CELL; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 0031892903     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678919903     Document Type: Short Survey

References (41)

1. Shoenfeld Y, Isenberg D. The Mosaic of Autoimmunity. Elsevier: Amsterdam, 1989.
2. Slavin S. Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders. Transplant Proc 1996; 28: 3021-3022
3. 1 preB cells. J Exp Med 1992, 176: 1343-1353.
4. Ikehara S et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoitic stem cells. Proc Natl Acad Sci USA 1990; 87: 8341-8344.
5. Ikehara S et al. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation. Prog Clin Biol Res 1987; 229: 131-146.
6. Levite M et al Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cell Immunol 1995; 162: 138-145
7. 1 mice by allogeneic bone marrow transplantation Immunobiology 1995; 192: 279-296.
8. Blank M et al. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. Arthritis Rheum 1995; 38: 115-122.
9. Blank M, Tomer Y, Slavin S, Shoenfeld Y. Induction of tolerance to experimental anti-phosphohpid syndrome (APS) by syngeneic bone marrow cell transplantation. Scand J Immunol 1995; 42: 226-234
10. Adachi Y et al. Effect of bone marrow transplantation on antiphospholipid antibody synrome in murine lupus mice. Immunobiology 1995, 192: 218-230.
11. Shoenfeld Y. Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 1994, 26 3211-3213.
12. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental APS: lessons from murine models. Lupus 1996; 5. 458-462
13. Hickey WF, Kimura H. Penvascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo Science 1988; 239: 290-292.
14. Karussis DM et al Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 1992; 39: 201-210
15. Karussis DM et al Prevention of experimental autoimmune encephalomyehtis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992; 148: 1693-1698.
16. Karussis DM et al. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest 1993; 92: 765-772.
17. Van-Gelder M, Mulder AH, van-Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation 1996; 62: 810-818.
18. Van-Gelder M, van-Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343-351
19. Leiter EH, Serreze DV. Autoimmune diabetes in the nonobese diabetic mouse: suppression of immune defects by bone marrow transplantation and implications for therapy Clin Immunol Immunopathol 1991; 59: 323-334.
20. Georgiou HM, Slattery RM, Charlton B. Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetes mice. Transplant Proc 1993; 25: 2896-2897
21. Ikehara S et al Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation Proc Natl Acad Sci USA 1985, 82: 7743-7747.
22. Yasumizu R et al Treatment of type 1 diabetes mellitus in nonobese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue Proc Natl Acad Sci USA 1987; 84: 6555-6557.
23. Mant MJ et al Immunosuppression as initial treatment for gold induced aplastic anemia. J Rheumatol 1987; 14: 1026-1029.
24. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993, 20: 137-140
25. Baldwin JL, Storb R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20. 1043-1048.
26. Yin JA, Jowitt SN. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 1992; 9: 31-33.
27. Vento S et al Resolution of autoimmune hepatitis after bone-marrow transplantation. Lancet 1996; 348. 544-545 (letter)
28. Nelson JL et al. Pre-existing autoimmune disease m patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 1997, 48 (Suppl): 23-29
29. Mckendry RJ, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation Arthritis Rheum 1996; 39: 1246-1253.
30. Jacobs P, Vincent MD, Martell RW. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia. Bone Marrow Transplant 1986; 1. 237-239
31. Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996; 55: 149-151.
32. Tyndail A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report writtrn on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390-392.
33. Tyndall A. Proceeding of the XIX ILAR Congress of Rheumatology, Syngapore, 8-13 June, 1997.
34. Brooks PM, Atkinson K, Hamilton JA. Stem cell transplantation in autoimmune disease. J Rheumatol 1995; 22: 1809-1811.
35. Marmont AM. Immune ablation with stem-cell rescue, a possible cure for systemic lupus erythematosus? Lupus 1993; 2: 151-156.
36. Wicks I, Cooley H, Szer J. Autologous hemopoietic stem cell transplantation a possible cure for rheumatoid arthritis? Arthritis Rheum 1997; 40: 1005-1011.
37. Mendonca LLF, Tyndall A Bone marrow transplantation in the treatment of autoimmune diseases: evolving concepts and early experience Lupus 1997; 6: 561-563.
38. Burt RK, Burns W, Hess A Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995; 16: 1-6.
39. Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous marrow stem cell transplantatton for severe systemic lupus erythematosus of long duration. Lupus 1997; 6. 545-548
40. Euler HH et al. Early recurrence or persistence of autoimmune diseases after uamampulated autologous stem cell transplantation. Blood 1996; 88: 3621-3625.
41. McSweeney PA el al Autologous stem cell transplantation for autoimmune diseases: issues in protocol development J Rheumatol 1997. 48 (Suppl) 79-84.